A year into the coronavirus pandemic and now with a vaccine finally approved by the TGA for use in Australia we speak with TSANZ president Professor Bruce Thompson about vaccine rollout and how COVID-19 will continue to affect the field of respiratory medicine. We also talk about TSANZs controversial position on e-cigarettes, the devastating lung condition silicosis and how changing the language we use to talk about respiratory conditions could help make the biggest difference to patient outcomes in 2021.